Keijiro Ishikawa

3.1k total citations
91 papers, 2.2k citations indexed

About

Keijiro Ishikawa is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Keijiro Ishikawa has authored 91 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Ophthalmology, 50 papers in Radiology, Nuclear Medicine and Imaging and 18 papers in Molecular Biology. Recurrent topics in Keijiro Ishikawa's work include Retinal Diseases and Treatments (56 papers), Retinal Imaging and Analysis (26 papers) and Retinal and Macular Surgery (25 papers). Keijiro Ishikawa is often cited by papers focused on Retinal Diseases and Treatments (56 papers), Retinal Imaging and Analysis (26 papers) and Retinal and Macular Surgery (25 papers). Keijiro Ishikawa collaborates with scholars based in Japan, United States and United Kingdom. Keijiro Ishikawa's co-authors include David R. Hinton, Shintaro Nakao, Ram Kannan, Shigeo Yoshida, Tatsuro Ishibashi, Yusuke Murakami, Toshio Hisatomi, Hiroshi Enaida, Takahito Nakama and Yasuhiro Ikeda and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Keijiro Ishikawa

79 papers receiving 2.2k citations

Peers

Keijiro Ishikawa
Goldis Malek United States
Lynn C. Shaw United States
Shu Kachi Japan
Paul McGuire United States
Shoujian Wang United States
Keijiro Ishikawa
Citations per year, relative to Keijiro Ishikawa Keijiro Ishikawa (= 1×) peers José Carlos Rivera

Countries citing papers authored by Keijiro Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Keijiro Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keijiro Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keijiro Ishikawa more than expected).

Fields of papers citing papers by Keijiro Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keijiro Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keijiro Ishikawa. The network helps show where Keijiro Ishikawa may publish in the future.

Co-authorship network of co-authors of Keijiro Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Keijiro Ishikawa. A scholar is included among the top collaborators of Keijiro Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keijiro Ishikawa. Keijiro Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wada, Iori, Yuji Oshima, Yosuke Fukuda, et al.. (2025). Five-year Outcome of Aflibercept Administration with “Treat and Extend” for Neovascular Age-Related Macular Degeneration. Clinical ophthalmology. Volume 19. 835–845. 1 indexed citations
2.
3.
Fukuda, Yosuke, Shoji Notomi, Satomi Shiose, et al.. (2024). Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(12). 3971–3978. 6 indexed citations
4.
Suzuki, Kiyoshi, Takashi Tachibana, Kenichiro Mori, et al.. (2023). Development of in situ crosslinked hyaluronan as an adjunct to vitrectomy surgery. Journal of Materials Science Materials in Medicine. 34(11). 56–56.
5.
Haruta, Masatoshi, et al.. (2023). Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema. Clinical ophthalmology. Volume 17. 239–245. 7 indexed citations
6.
Notomi, Shoji, Satomi Shiose, Yosuke Fukuda, et al.. (2022). Characteristics of Retinal Pigment Epithelium Elevations Preceding Exudative Age-Related Macular Degeneration in Japanese. Ophthalmic Research. 66(1). 108–115. 1 indexed citations
7.
Notomi, Shoji, Satomi Shiose, Keijiro Ishikawa, et al.. (2021). Drusen and pigment abnormality predict the development of neovascular age-related macular degeneration in Japanese patients. PLoS ONE. 16(7). e0255213–e0255213. 14 indexed citations
8.
Kubo, Yuki, Keijiro Ishikawa, Kenichiro Mori, et al.. (2020). Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy. Scientific Reports. 10(1). 9299–9299. 19 indexed citations
9.
Nakao, Shintaro, Takehiro Hayashi, Yoshihiro Kaizu, et al.. (2019). Vessel Tortuosity Measurement in Epiretinal Membrane in Optical Coherence Tomography Angiography. Investigative Ophthalmology & Visual Science. 60(9). 1280–1280. 1 indexed citations
10.
Kaizu, Yoshihiro, Shintaro Nakao, Iori Wada, et al.. (2019). Microaneurysm Imaging Using Multiple En Face OCT Angiography Image Averaging. Ophthalmology Retina. 4(2). 175–186. 33 indexed citations
11.
Wada, Iori, Shigeo Yoshida, Yoshiyuki Kobayashi, et al.. (2017). Quantifying metamorphopsia with M-CHARTS in patients with idiopathic macular hole. Clinical ophthalmology. Volume 11. 1719–1726. 10 indexed citations
12.
Nakama, Takahito, Shigeo Yoshida, Keijiro Ishikawa, et al.. (2017). Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization. Molecular Therapy — Nucleic Acids. 6. 279–289. 18 indexed citations
13.
Kobayashi, Yoshiyuki, Shigeo Yoshida, Yedi Zhou, et al.. (2016). Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.. PubMed Central. 22. 436–45. 24 indexed citations
14.
Zhou, Yedi, Shigeo Yoshida, Yuki Kubo, et al.. (2016). Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy. Scientific Reports. 6(1). 28140–28140. 31 indexed citations
15.
Sassa, Yukio, et al.. (2016). The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy. Eye. 30(5). 746–753. 12 indexed citations
16.
Kobayashi, Yoshiyuki, Shigeo Yoshida, Yedi Zhou, et al.. (2016). Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV. Laboratory Investigation. 96(11). 1178–1188. 20 indexed citations
17.
Sassa, Yukio, Shigeo Yoshida, Keijiro Ishikawa, et al.. (2013). The significant relationships between Fibronectin, Tenascin-C and Periostin in the eyes of the patients with diabetic retinopathy. Investigative Ophthalmology & Visual Science. 54(15). 1160–1160. 1 indexed citations
18.
Yoshida, Noriko, Yasuhiro Ikeda, Shoji Notomi, et al.. (2013). Relation between Sustained Chronic Inflammatory Reaction and Oxidative Damage in an Animal Model of Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science. 54(15). 658–658. 1 indexed citations
19.
Asato, Ryo, Shigeo Yoshida, Atsushi Ogura, et al.. (2013). Comparison of Gene Expression Profile of Epiretinal Membranes Obtained from Eyes with Proliferative Vitreoretinopathy to That of Secondary Epiretinal Membranes. PLoS ONE. 8(1). e54191–e54191. 32 indexed citations
20.
Yoshida, Noriko, Yasuhiro Ikeda, Shoji Notomi, et al.. (2012). Clinical Evidence of Sustained Chronic Inflammatory Reaction in Retinitis Pigmentosa. Ophthalmology. 120(1). 100–105. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026